In order to confirm whether somatodendritic SYNJ1 immunoreactivity was associated with neuropathological lesions in the AD hippocampus, a double immunostaining was carried out using anti-SYNJ1 and PHF1 antibodies (Fig. 2a-l). This evidence concerns the gene SYNJ1 and Alzheimer disease.